Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study
Authors
Saltz, Leonard B.; Lenz, Heinz-Josef; Kindler, Hedy L.; Hochster, Howard S.; Wadler, Scott; Hoff, Paulo M.; Kemeny, Nancy E.; Hollywood, Ellen M.; Gonen, Mithat; Quinones, Marcus; Morse, Meroe; Chen, Helen X.
Publication
Journal of Clinical Oncology, 2007, Vol 25, Issue 29, p4557